Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
G-2535 in Women at High Risk for Breast Cancer
NCT00290758Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Jan 2006
- Primary completion
- Mar 2009
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of genistein in breast cancer, sponsored by National Cancer Institute. Started Jan 2006; status: completed.
02
Drugs
genistein
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00290758.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00290758.